Invention Grant
- Patent Title: Non-selective kinase inhibitors
-
Application No.: US15660551Application Date: 2017-07-26
-
Publication No.: US10246438B2Publication Date: 2019-04-02
- Inventor: Lawrence S Zisman
- Applicant: Pulmokine, Inc. , GILEAD SCIENCES, INC.
- Applicant Address: US NY Rensselaer
- Assignee: PULMOKINE, INC
- Current Assignee: PULMOKINE, INC
- Current Assignee Address: US NY Rensselaer
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D403/12 ; C07D241/20 ; A61K31/4965
Abstract:
Disclosed herein are compounds, compositions, and methods for preventing and treating proliferative diseases associated with aberrant receptor tyrosine kinase (RTK) activity. The therapeutic indications described herein more specifically relate to the non-selective inhibition of RTKs associated with vascular and pulmonary disorders.
Public/Granted literature
- US20180162837A1 NON-SELECTIVE KINASE INHIBITORS Public/Granted day:2018-06-14
Information query
